Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Andreoni and Sergio Bernardini.
Connection Strength
1.370
-
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection. Int Immunopharmacol. 2021 Oct; 99:108013.
Score: 0.240
-
Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection. J Med Virol. 2021 May; 93(5):2988-2991.
Score: 0.232
-
Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus. Int Immunopharmacol. 2021 Mar; 92:107330.
Score: 0.230
-
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov. 2020; 6:38.
Score: 0.221
-
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front Pharmacol. 2021; 12:666600.
Score: 0.059
-
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine. 2021 Apr; 66:103341.
Score: 0.059
-
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. J Am Coll Nutr. 2021 Feb 18; 1-16.
Score: 0.058
-
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa588.
Score: 0.057
-
HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020 11; 96(5):610-614.
Score: 0.056
-
COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. Genes (Basel). 2020 08 27; 11(9).
Score: 0.056
-
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2. Clin Med (Lond). 2020 07; 20(4):e114-e119.
Score: 0.056
-
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. PLoS One. 2017; 12(5):e0177352.
Score: 0.045